Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|October 24, 2017
Nicotine Metabolism-informed Care for Smoking Cessation: A Pilot Precision RCTQuinn S Wells, Matthew S Freiberg, Robert A Greevy, et al.
The American Journal of Gastroenterology|April 6, 2016
Association Between Affective-Cognitive Symptoms of Depression and Exacerbation of Crohn's DiseaseLawrence S Gaines, James C Slaughter, Sara N Horst, et al.
Journal of the Pediatric Infectious Diseases Society|March 26, 2016
Vertical Transmission of Histoplasmosis Associated With Anti-Tumor Necrosis Factor TherapyJames G Carlucci, Natasha Halasa, C Buddy Creech, et al.
Plos One|May 27, 2016
Serum Fatty Acids Are Correlated with Inflammatory Cytokines in Ulcerative ColitisDawn M Wiese, Sara N Horst, Caroline T Brown, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 21, 2007
Impact of Clostridium difficile on inflammatory bowel diseaseMazen Issa, Aravind Vijayapal, Mary Beth Graham, et al.
Gastroenterology|January 13, 2010
Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitisWilliam J Sandborn, Joshua Korzenik, Bret Lashner, et al.
Crohn'S & Colitis 360|February 13, 2023
Clinical Course and Impact of Immune Checkpoint Inhibitor Colitis Resembling Microscopic ColitisThomas W Fredrick, Guilherme P Ramos, Manuel B Braga Neto, et al.
Scientific Reports|March 1, 2019
Serum Polyunsaturated Fatty Acids Correlate with Serum Cytokines and Clinical Disease Activity in Crohn's DiseaseElizabeth A Scoville, Margaret M Allaman, Dawn W Adams, et al.
Metabolomics : Official Journal of the Metabolomic Society|April 24, 2018
Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn's Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic ProfilingElizabeth A Scoville, Margaret M Allaman, Caroline T Brown, et al.
Inflammatory Bowel Diseases|November 9, 2020
The Impact of Vedolizumab on Pre-Existing Extraintestinal Manifestations of Inflammatory Bowel Disease: A Multicenter StudyGuilherme Piovezani Ramos, Christina Dimopoulos, Nicholas M McDonald, et al.
Pageof 16